Vir Biotechnology (VIR) is advancing its ECLIPSE phase 3 program for tobevibart + elebsiran in Hepatitis Delta Virus, with topline data from all 3 studies expected Q1 2027. Company's dual-masked ...
VANCOUVER, BC / ACCESS Newswire / October 29, 2025 / Darren Ewert and Mike Dreher, co-founders of the Dream Team mentorship program, have officially launched a new training initiative designed for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback